Industry News
Outstanding Australian scientists recognised with election to the Australian Academy of Science
A contributor to discoveries at the large hadron collider at CERN, the researcher who determined the molecular mechanism behind coral bleaching, and a leader in human disease gene mapping are among 20 new Fellows to be elected to the Australian Academy of Science in 2013. [ + ]
Superfast plant breeding
A plant breeding project promises pure-line plant genotypes to increase food production. [ + ]
AusBiotech appoints global life sciences fund manager as new board member
AusBiotech has announced the appointment of Lawrence Gozlan as a non-executive director, bringing to the board global capital markets experience and specialist knowledge in life sciences investing. [ + ]
Cellmid close to royalties on cancer test licences
Cellmid (ASX:CDY) has provided an update on the two cancer diagnostics tests under development by its licensees using midkines as a biomarker. [ + ]
Stay away from bats
Another death in Australia from lyssavirus prompts experts to warn people to avoid contact with bats and flying foxes. [ + ]
Strong early results from Viralytics melanoma trial
A lead investigator for Viralytics’ (ASX:VLA) phase II trial of Cavatak in melanoma has presented some preliminary results from his leg of the study. [ + ]
Phosphagenics’ new opioid patch clears phase I
Phosphagenics’ (ASX:POH) TPM-Oxymorphone patch, its second opioid-based pain patch in development, has met its delivery targets in a phase I trial. [ + ]
Phylogica gets Australian Phylomer patent
Phylogica (ASX:PYC) has won an Australian patent covering its Phylomer peptide libraries as a composition of matter. [ + ]
Screening human blood for disease markers
Researchers at The Scripps Research Institute in Florida have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today’s most pressing and puzzling health conditions, including autoimmune diseases. [ + ]
Spectral colour technology enables accurate colour imaging
In the near future, spectral imaging will provide new solutions for environmental monitoring and industrial quality control. [ + ]
Plant scientist off to study US corn as Fulbright scholar
A young plant biologist who developed a passion for the environment when he took up surfing in primary school has been awarded a 2013 Fulbright Western Australia Scholarship to undertake research in the US. [ + ]
Melanoma trial recruitment accelerating
Viralytics (ASX:VLA) has signed on 12 patients in the last three months for its phase II trial of oncolytic virus Cavatak in patients with late-stage melanoma. [ + ]
Alchemia appoints two new board members
Alchemia (ASX:ACL) has added an oncology expert and an international investment banking veteran to its board. [ + ]
New malaria drug could help combat resistance
Dr Aaron Nilsen and colleagues have discovered a new drug called ELQ-300 that can target multiple stages of the malaria parasite’s life cycle, including the liver stage, and could dramatically boost the prevention, treatment and transmission of disease. [ + ]
Genetics closer to understanding the elusive giant squid
Research suggests that there is just one single species of giant squid, capable of long-distance travel, rather than the 21 previously described species that were thought to exist. [ + ]
